What is the recommended dose of vitamin K (Vitamin K1, phylloquinone) for a newborn?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vitamin K Dosing for Newborns

All healthy term newborns should receive a single intramuscular dose of 0.5 to 1 mg vitamin K1 within one hour of birth, as this is the most effective route for preventing vitamin K deficiency bleeding. 1, 2

Route of Administration

Intramuscular administration is strongly preferred over oral routes because it provides superior protection against all forms of vitamin K deficiency bleeding (VKDB), particularly late VKDB which can occur up to 6 months of age. 2, 3, 4

  • The IM route ensures reliable absorption and compliance, eliminating concerns about regurgitation, vomiting, or missed follow-up doses that plague oral regimens. 2
  • The FDA-approved dose is 0.5 to 1 mg given intramuscularly within one hour of birth. 1

Oral Alternative (Second-Line Only)

If parents decline IM vitamin K after adequate counseling about increased bleeding risk, oral administration may be offered as a compromise, though it is less effective: 2, 3, 4

Three acceptable oral regimens exist:

  • Option 1: 2 mg at birth, repeated at 4-6 days, and again at 4-6 weeks 2
  • Option 2: 2 mg at birth, then 1 mg weekly for 3 months 2
  • Option 3: 3 doses of 2 mg each at birth, 2-4 weeks, and 6-8 weeks 3, 4

Critical Oral Regimen Caveats

  • If the infant vomits or regurgitates within 1 hour of oral administration, repeat the dose. 2
  • Compliance with multi-dose oral regimens is problematic—studies show up to 25% of infants miss recommended doses, placing them at increased risk. 5
  • Parents must understand that oral prophylaxis carries higher VKDB risk than IM administration. 3, 4

Special Populations Requiring IM Route

The oral route is contraindicated and IM (or IV if necessary) must be used in: 2, 6

  • Preterm infants
  • Infants with cholestasis or malabsorption disorders
  • Infants too ill to take oral medications
  • Infants whose mothers took medications interfering with vitamin K metabolism (anticonvulsants, anticoagulants, antituberculosis drugs)
  • Infants at high risk of hemorrhage (birth asphyxia, difficult delivery, neonatal disease)

For these high-risk infants, higher doses may be necessary if maternal anticoagulant exposure occurred, and repeated dosing should be individualized based on coagulation studies. 1, 6

Preterm Infants on Parenteral Nutrition

Preterm infants receiving parenteral nutrition require 10 μg/kg/day of vitamin K as part of their daily nutritional support, which differs from the prophylactic birth dose. 7, 8, 9

Documentation Requirements

The date, dose, and route of vitamin K administration must be documented in the medical record. 2

Parental refusal must be explicitly recorded due to the serious risk of late VKDB, which can present with catastrophic intracranial hemorrhage. 2

References

Research

Guidelines for vitamin K prophylaxis in newborns.

Paediatrics & child health, 2018

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Vitamin K Prophylaxis for Newborns

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Vitamin K1 Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.